Kenneth T. Jones, See Remarks at Zynerba Pharmaceuticals, Inc. (ZYNE), sold 2,505 shares at $1.33 ($3K) on 2023-09-13, disclosed to the SEC on 2023-09-14.
Open-market sale of $3k ZYNE by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.